1. Home
  2. KSCP vs XLO Comparison

KSCP vs XLO Comparison

Compare KSCP & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Knightscope Inc.

KSCP

Knightscope Inc.

HOLD

Current Price

$2.95

Market Cap

58.1M

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$8.19

Market Cap

49.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KSCP
XLO
Founded
2013
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.1M
49.8M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
KSCP
XLO
Price
$2.95
$8.19
Analyst Decision
Strong Buy
Buy
Analyst Count
3
1
Target Price
$17.00
$28.00
AVG Volume (30 Days)
470.2K
32.4K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
63.54
N/A
EPS
N/A
N/A
Revenue
$11,335,000.00
$43,766,000.00
Revenue This Year
$218.66
N/A
Revenue Next Year
$54.32
$168.77
P/E Ratio
N/A
N/A
Revenue Growth
4.91
589.88
52 Week Low
$2.52
$0.46
52 Week High
$10.13
$9.25

Technical Indicators

Market Signals
Indicator
KSCP
XLO
Relative Strength Index (RSI) 46.09 57.52
Support Level $2.52 $0.62
Resistance Level $4.50 $9.03
Average True Range (ATR) 0.23 0.44
MACD 0.03 -0.01
Stochastic Oscillator 62.01 60.31

Price Performance

Historical Comparison
KSCP
XLO

About KSCP Knightscope Inc.

Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: